Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/69829, first published .
Methadone Patient Access to Collaborative Treatment: Protocol for a Pilot and a Randomized Controlled Trial to Establish Feasibility of Adoption and Impact on Methadone Treatment Delivery and Patient Outcomes

Methadone Patient Access to Collaborative Treatment: Protocol for a Pilot and a Randomized Controlled Trial to Establish Feasibility of Adoption and Impact on Methadone Treatment Delivery and Patient Outcomes

Methadone Patient Access to Collaborative Treatment: Protocol for a Pilot and a Randomized Controlled Trial to Establish Feasibility of Adoption and Impact on Methadone Treatment Delivery and Patient Outcomes

Beth E Meyerson   1, 2 , MDiv, PhD ;   Alissa Davis   1, 3 , PhD, MA ;   Richard A Crosby   1, 4 , PhD, MA ;   Linnea B Linde-Krieger   1, 2 , PhD ;   Benjamin R Brady   1, 2, 5 , MA, DrPH ;   Gregory A Carter   1, 6 , MSN, PhD ;   Arlene N Mahoney   1, 7 , MSW ;   David Frank   1, 8 , PhD, MA ;   Janet Rothers   1, 9 , PhD, MS ;   Zhanette Coffee   1, 2, 10 , MSN, PhD ;   Elana Deuble   11 , MSW ;   Jonathon Ebert   11 ;   Mary F Jablonsky   11 ;   Marlena Juarez   11 ;   Barbara Lee   12 ;   Heather M Lorenz   12 , BSW ;   Michael D Pava   11 , MA ;   Kristen Tinsely   11 ;   Sana Yousaf   1

1 Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson, Tucson, AZ, United States

2 Comprehensive Center for Pain and Addiction, University of Arizona Health Sciences, University of Arizona, Tucson, AZ, United States

3 School of Social Work, Columbia University, New York, NY, United States

4 College of Public Health, University of Kentucky, Lexington, KY, United States

5 College of Health and Human Services, School of Interdisciplinary Health Programs, Western Michigan University, Kalamazoo, MI, United States

6 School of Nursing, Indiana University, Bloomington, IN, United States

7 Southwest Recovery Alliance, Phoenix, AZ, United States

8 School of Global Health, New York University, New York, NY, United States

9 StatLab, BIO5 Institute, University of Arizona, Tucson, AZ, United States

10 College of Nursing, University of Arizona, Tucson, AZ, United States

11 Community Medical Services, Phoenix, AZ, United States

12 Drug Policy Research and Advocacy Board, Tucson, AZ, United States

Corresponding Author:

  • Beth E Meyerson, MDiv, PhD
  • Harm Reduction Research Lab
  • University of Arizona College of Medicine-Tucson
  • 655 N Alvernon Way
  • Tucson, AZ 85711
  • United States
  • Phone: 1 520 626 0275
  • Email: bmeyerson@arizona.edu